Orexigen Therapeutics Inc (OTC Pink - No Information:OREXQ)

0.145
Delayed Data
As of May 25
 -0.0115 / -7.35%
Today’s Change
0.09
Today|||52-Week Range
3.13
-88.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-77.7M-37.5M-68.7M-24.5M
 
 
 
 
 
Depreciation94.0K139.0K223.0K3.7M
 
 
 
 
 
Total Other Cash Flow8.6M20.0M20.5M-100.9M
 
 
 
 
 
Funds From Operations-69.0M-17.4M-48.0M-121.7M
 
 
 
 
 
Funds From/For Other Operating Expenses1.8M-44.2M6.5M-12.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-70.8M26.8M-54.5M-109.7M
 
 
 
 
 
 
InvestingIncrease In Investments-85.6M-130.4M-119.6M-113.8M
 
 
 
 
 
Decrease In Investments65.0M107.2M161.6M70.6M
 
 
 
 
 
Capital Expenditures-640.0K-246.0K-538.0K-330.0K
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-63.5M
 
 
Net Cash Flow Investing-21.3M-23.4M41.4M-107.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings110.5M0.000.00120.0M
 
 
 
Long Term Debt Reduction0.000.000.00-10.0M
 
 
Net Proceeds Stock Sale1.3M2.7M64.3M44.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing111.9M2.7M64.3M154.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00-29.0K-715.0K
 
 
 
 
Net Change In Cash19.8M6.1M51.2M-62.2M